Skip to main content
Top
Published in: Drug Safety 1/2013

01-01-2013 | Original Research Article

Maternal Recall of Prescription Medication Use During Pregnancy Using a Paper-Based Questionnaire

A Validation Study in The Netherlands

Authors: Marleen M. H. J. van Gelder, Iris A. L. M. van Rooij, Hermien E. K. de Walle, Nel Roeleveld, Marian K. Bakker

Published in: Drug Safety | Issue 1/2013

Login to get access

Abstract

Background

In case-control studies that assess associations between medication use and birth defects, detailed information on type of medication and timing of use is essential to prevent misclassification. However, data on the accuracy of recall of medication use during pregnancy are scarce.

Objective

The aim of this study was to validate a self-administered questionnaire to assess prescription medication use in the 3 months before and during pregnancy.

Methods

This validation study was embedded in Eurocat Northern Netherlands, a population-based birth defects registry that covers 10 % of all births in The Netherlands. The questionnaire was validated among 560 mothers of infants with major birth defects registered from 1 January 2009 through 30 June 2010 by comparing it with a reference standard consisting of pharmacy data which were checked for compliance by maternal interviews. Sensitivity and specificity were calculated to quantify validity for any prescription medication use, groups of medications and individual medications. In addition, we determined whether maternal characteristics influenced disagreement between the questionnaire and the reference standard using logistic regression analyses.

Results

The sensitivity for any prescription medication use was 0.57, ranging between 0.07 (dermatological corticosteroids) and 0.83 (antihypertensives) for medication groups, and between 0.00 (naproxen) and 0.73 (salbutamol) for individual medications. Overall, specificity was high (0.93–1.00). Smoking during pregnancy and completing the questionnaire >2 years after delivery were associated with increased disagreement between the questionnaire for prescription medication use and the reference standard.

Conclusions

The validity of the self-administered questionnaire for prescription medication use during pregnancy was moderate to poor for most medications and disagreement differed by some maternal characteristics. As many epidemiological studies use similar questionnaires to assess medication use these studies may need additional data sources such as pharmacy records or prescription databases for medication use next to self-reported methods. Also, previous knowledge on the effect of questionnaire design should be taken into account.
Appendix
Available only for authorised users
Literature
1.
go back to reference Olesen C, Steffensen FH, Nielsen GL, et al. Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur J Clin Pharmacol. 1999;55(2):139–44.PubMedCrossRef Olesen C, Steffensen FH, Nielsen GL, et al. Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur J Clin Pharmacol. 1999;55(2):139–44.PubMedCrossRef
2.
go back to reference Bakker MK, Jentink J, Vroom F, et al. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG. 2006;113(5):559–68.PubMedCrossRef Bakker MK, Jentink J, Vroom F, et al. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG. 2006;113(5):559–68.PubMedCrossRef
3.
go back to reference Engeland A, Bramness JG, Daltveit AK, et al. Prescription drug use among fathers and mothers before and during pregnancy: a population-based cohort study of 106 000 pregnancies in Norway 2004–2006. Br J Clin Pharmacol. 2008;65(5):653–60.PubMedCrossRef Engeland A, Bramness JG, Daltveit AK, et al. Prescription drug use among fathers and mothers before and during pregnancy: a population-based cohort study of 106 000 pregnancies in Norway 2004–2006. Br J Clin Pharmacol. 2008;65(5):653–60.PubMedCrossRef
4.
go back to reference Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet Part C Semin Med Genet. 2011;157(3):175–82.PubMedCrossRef Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet Part C Semin Med Genet. 2011;157(3):175–82.PubMedCrossRef
5.
go back to reference Friedman JM. How do we know if an exposure is actually teratogenic in humans? Am J Med Genet Part C Semin Med Genet. 2011;157(3):170–4.PubMedCrossRef Friedman JM. How do we know if an exposure is actually teratogenic in humans? Am J Med Genet Part C Semin Med Genet. 2011;157(3):170–4.PubMedCrossRef
6.
go back to reference Murk W, Risnes KR, Bracken MB. Prenatal or early-life exposure to antibiotics and risk of childhood asthma: a systematic review. Pediatrics. 2011;127(6):1125–38.PubMedCrossRef Murk W, Risnes KR, Bracken MB. Prenatal or early-life exposure to antibiotics and risk of childhood asthma: a systematic review. Pediatrics. 2011;127(6):1125–38.PubMedCrossRef
7.
go back to reference Pasker-de Jong PCM, Zielhuis GA, van Gelder MMHJ, et al. Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study. BJOG. 2010;117(9):1080–7.PubMedCrossRef Pasker-de Jong PCM, Zielhuis GA, van Gelder MMHJ, et al. Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study. BJOG. 2010;117(9):1080–7.PubMedCrossRef
8.
go back to reference Van Gelder MMHJ, van Rooij IALM, Miller RK, et al. Teratogenic mechanisms of medical drugs. Hum Reprod Update. 2010;16(4):378–94.PubMedCrossRef Van Gelder MMHJ, van Rooij IALM, Miller RK, et al. Teratogenic mechanisms of medical drugs. Hum Reprod Update. 2010;16(4):378–94.PubMedCrossRef
9.
go back to reference De Jong-van den Berg LTW, Waardenburg CM, Haaijer-Ruskamp FM, et al. Drug use in pregnancy: a comparative appraisal of data collecting methods. Eur J Clin Pharmacol. 1993;45(1): 9–14. De Jong-van den Berg LTW, Waardenburg CM, Haaijer-Ruskamp FM, et al. Drug use in pregnancy: a comparative appraisal of data collecting methods. Eur J Clin Pharmacol. 1993;45(1): 9–14.
10.
go back to reference De Jong van den Berg LTW, Feenstra N, Sorensen HT, et al. Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. Teratology. 1999;60(1): 33–36. De Jong van den Berg LTW, Feenstra N, Sorensen HT, et al. Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. Teratology. 1999;60(1): 33–36.
11.
go back to reference Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol. 1986;123(4):670–6.PubMed Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol. 1986;123(4):670–6.PubMed
12.
go back to reference De Jong PCM, Huijsmans AA, Nienhuis HE, et al. Validation of a questionnaire on medical drug use during pregnancy. Am J Epidemiol. 1991;134(9):998–1002.PubMed De Jong PCM, Huijsmans AA, Nienhuis HE, et al. Validation of a questionnaire on medical drug use during pregnancy. Am J Epidemiol. 1991;134(9):998–1002.PubMed
13.
go back to reference Newport DJ, Brennan PA, Green P, et al. Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation. BJOG. 2008;115(6):681–8.PubMedCrossRef Newport DJ, Brennan PA, Green P, et al. Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation. BJOG. 2008;115(6):681–8.PubMedCrossRef
14.
go back to reference Olesen C, Søndergaard C, Thrane N, et al. Do pregnant women report use of dispensed medications? Epidemiology. 2001;12(5):497–501.PubMedCrossRef Olesen C, Søndergaard C, Thrane N, et al. Do pregnant women report use of dispensed medications? Epidemiology. 2001;12(5):497–501.PubMedCrossRef
15.
go back to reference Larsson M. A descriptive study of the use of the Internet by women seeking pregnancy-related information. Midwifery. 2009;25(1):14–20.PubMedCrossRef Larsson M. A descriptive study of the use of the Internet by women seeking pregnancy-related information. Midwifery. 2009;25(1):14–20.PubMedCrossRef
16.
go back to reference Lagan BM, Sinclair M, Kernohan WG. Internet use in pregnancy informs women’s decision making: a web-based survey. Birth. 2010;37(2):106–15.PubMedCrossRef Lagan BM, Sinclair M, Kernohan WG. Internet use in pregnancy informs women’s decision making: a web-based survey. Birth. 2010;37(2):106–15.PubMedCrossRef
17.
go back to reference Weinberg CR, Wilcox AJ. Methodologic issues in reproductive epidemiology. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 620–40. Weinberg CR, Wilcox AJ. Methodologic issues in reproductive epidemiology. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 620–40.
19.
go back to reference Reefhuis J, de Walle HEK, de Jong-van den Berg LTW, et al. Additional information from parental questionnaires and pharmacy records for registration of birth defects. Eur J Epidemiol. 2000;16(4):329–36.PubMedCrossRef Reefhuis J, de Walle HEK, de Jong-van den Berg LTW, et al. Additional information from parental questionnaires and pharmacy records for registration of birth defects. Eur J Epidemiol. 2000;16(4):329–36.PubMedCrossRef
20.
go back to reference Leufkens HG, Urquhart J. Automated pharmacy record linkage in the Netherlands. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. Chichester: Wiley; 2005. p. 311–22. Leufkens HG, Urquhart J. Automated pharmacy record linkage in the Netherlands. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. Chichester: Wiley; 2005. p. 311–22.
21.
go back to reference Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997;50(5):619–25.PubMedCrossRef Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997;50(5):619–25.PubMedCrossRef
22.
go back to reference Donders ART, van der Heijden GJMG, Stijnen T, et al. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59(10):1087–91.PubMedCrossRef Donders ART, van der Heijden GJMG, Stijnen T, et al. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59(10):1087–91.PubMedCrossRef
23.
go back to reference Rockenbauer M, Olsen J, Czeizel AE, et al. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001;12(4):461–6.PubMedCrossRef Rockenbauer M, Olsen J, Czeizel AE, et al. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001;12(4):461–6.PubMedCrossRef
24.
go back to reference Mackenzie SG, Lippman A. An investigation of report bias in a case-control study of pregnancy outcome. Am J Epidemiol. 1989;129(1):65–75.PubMed Mackenzie SG, Lippman A. An investigation of report bias in a case-control study of pregnancy outcome. Am J Epidemiol. 1989;129(1):65–75.PubMed
25.
go back to reference Khoury MJ, James LM, Erickson JD. On the use of affected controls to address recall bias in case-control studies of birth defects. Teratology. 1994;49(4):273–81.PubMedCrossRef Khoury MJ, James LM, Erickson JD. On the use of affected controls to address recall bias in case-control studies of birth defects. Teratology. 1994;49(4):273–81.PubMedCrossRef
26.
go back to reference Werler MM, Pober BR, Nelson K, et al. Reporting accuracy among mothers of malformed and nonmalformed infants. Am J Epidemiol. 1989;129(2):415–21.PubMed Werler MM, Pober BR, Nelson K, et al. Reporting accuracy among mothers of malformed and nonmalformed infants. Am J Epidemiol. 1989;129(2):415–21.PubMed
27.
go back to reference Sou SC, Chen WJ, Hsieh WS, et al. Severe obstetric complications and birth characteristics in preterm or term delivery were accurately recalled by mothers. J Clin Epidemiol. 2006;59(4):429–35.PubMedCrossRef Sou SC, Chen WJ, Hsieh WS, et al. Severe obstetric complications and birth characteristics in preterm or term delivery were accurately recalled by mothers. J Clin Epidemiol. 2006;59(4):429–35.PubMedCrossRef
28.
go back to reference Olson JE, Shu XO, Ross JA, et al. Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children’s Cancer Group. Am J Epidemiol. 1997;145(1):58–67.PubMedCrossRef Olson JE, Shu XO, Ross JA, et al. Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children’s Cancer Group. Am J Epidemiol. 1997;145(1):58–67.PubMedCrossRef
29.
go back to reference Quigley MA, Hockley C, Davidson LL. Agreement between hospital records and maternal recall of mode of delivery: evidence from 12 391 deliveries in the UK Millennium Cohort Study. BJOG. 2007;114(2):195–200.PubMedCrossRef Quigley MA, Hockley C, Davidson LL. Agreement between hospital records and maternal recall of mode of delivery: evidence from 12 391 deliveries in the UK Millennium Cohort Study. BJOG. 2007;114(2):195–200.PubMedCrossRef
30.
go back to reference Tate AR, Dezateux C, Cole TJ, et al. Factors affecting a mother’s recall of her baby’s birth weight. Int J Epidemiol. 2005;34(3):688–95.PubMedCrossRef Tate AR, Dezateux C, Cole TJ, et al. Factors affecting a mother’s recall of her baby’s birth weight. Int J Epidemiol. 2005;34(3):688–95.PubMedCrossRef
31.
go back to reference Troude P, L’Hélias LF, Raison-Boulley AM, et al. Perinatal factors reported by mothers: do they agree with medical records? Eur J Epidemiol. 2008;23(8):557–64.PubMedCrossRef Troude P, L’Hélias LF, Raison-Boulley AM, et al. Perinatal factors reported by mothers: do they agree with medical records? Eur J Epidemiol. 2008;23(8):557–64.PubMedCrossRef
32.
go back to reference Poulsen G, Kurinczuk JJ, Wolke D, et al. Accurate reporting of expected delivery date by mothers 9 months after birth. J Clin Epidemiol. 2011;64(12):1444–50.PubMedCrossRef Poulsen G, Kurinczuk JJ, Wolke D, et al. Accurate reporting of expected delivery date by mothers 9 months after birth. J Clin Epidemiol. 2011;64(12):1444–50.PubMedCrossRef
33.
go back to reference Tilley BC, Barnes AB, Bergstralh E, et al. A comparison of pregnancy history recall and medical records: implications for retrospective studies. Am J Epidemiol. 1985;121(2):269–81.PubMed Tilley BC, Barnes AB, Bergstralh E, et al. A comparison of pregnancy history recall and medical records: implications for retrospective studies. Am J Epidemiol. 1985;121(2):269–81.PubMed
34.
go back to reference Elkadry E, Kenton K, White P, et al. Do mothers remember key events during labor? Am J Obstet Gynecol. 2003;189(1):195–200.PubMedCrossRef Elkadry E, Kenton K, White P, et al. Do mothers remember key events during labor? Am J Obstet Gynecol. 2003;189(1):195–200.PubMedCrossRef
35.
go back to reference Van den Brandt PA, Petri H, Dorant E, et al. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci. 1991;13(2):91–6.PubMedCrossRef Van den Brandt PA, Petri H, Dorant E, et al. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci. 1991;13(2):91–6.PubMedCrossRef
36.
go back to reference Coolman M, de Groot CJM, Jaddoe VW, et al. Medical record validation of maternally reported history of preeclampsia. J Clin Epidemiol. 2010;63(8):932–7.PubMedCrossRef Coolman M, de Groot CJM, Jaddoe VW, et al. Medical record validation of maternally reported history of preeclampsia. J Clin Epidemiol. 2010;63(8):932–7.PubMedCrossRef
37.
go back to reference Lieff S, Olshan AF, Werler M, et al. Selection bias and the use of controls with malformations in case-control studies of birth defects. Epidemiology. 1999;10(3):238–41.PubMedCrossRef Lieff S, Olshan AF, Werler M, et al. Selection bias and the use of controls with malformations in case-control studies of birth defects. Epidemiology. 1999;10(3):238–41.PubMedCrossRef
38.
go back to reference Bakker MK, de Walle HEK, Dequito A, et al. Selection of controls in case-control studies on maternal medication use and risk of birth defects. Birth Defects Res A Clin Mol Teratol. 2007;79(9):652–6.PubMedCrossRef Bakker MK, de Walle HEK, Dequito A, et al. Selection of controls in case-control studies on maternal medication use and risk of birth defects. Birth Defects Res A Clin Mol Teratol. 2007;79(9):652–6.PubMedCrossRef
39.
go back to reference Rothman KJ, Greenland S, Lash TL. Validity in epidemiologic studies. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 128–47. Rothman KJ, Greenland S, Lash TL. Validity in epidemiologic studies. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 128–47.
40.
go back to reference Klungel OH, de Boer A, Paes AHP, et al. Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol. 2000;53(3):273–7.PubMedCrossRef Klungel OH, de Boer A, Paes AHP, et al. Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol. 2000;53(3):273–7.PubMedCrossRef
41.
go back to reference Gama H, Correia S, Lunet N. Questionnaire design and the recall of pharmacological treatments: a systematic review. Pharmacoepidemiol Drug Saf. 2009;18(3):175–87.PubMedCrossRef Gama H, Correia S, Lunet N. Questionnaire design and the recall of pharmacological treatments: a systematic review. Pharmacoepidemiol Drug Saf. 2009;18(3):175–87.PubMedCrossRef
Metadata
Title
Maternal Recall of Prescription Medication Use During Pregnancy Using a Paper-Based Questionnaire
A Validation Study in The Netherlands
Authors
Marleen M. H. J. van Gelder
Iris A. L. M. van Rooij
Hermien E. K. de Walle
Nel Roeleveld
Marian K. Bakker
Publication date
01-01-2013
Publisher
Springer International Publishing AG
Published in
Drug Safety / Issue 1/2013
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.1007/s40264-012-0004-8

Other articles of this Issue 1/2013

Drug Safety 1/2013 Go to the issue